Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIDE: Depiquick Birch Immunotherapy in Allergic Rhinitis/Rhinoconjunctivitis
NCT01902992Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2012
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
A Phase 3 trial of Depiquick Birch in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC), sponsored by Novartis. Started Mar 2012; status: completed.
02
Drugs
Depiquick Birch
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT01902992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902992.